Humanoid Power List
Provisionalmedium confidence

Zhou Jian

Chairman, Executive Director and CEO · UBTECH

Joint eighth: balanced humanoid engineering, mobilisation and commercial pathways; no dominant general-model or ecosystem claim earns 5.

Rank
8
80 /100

Analysis

Established position

UBTECH’s August interim announcement identifies Zhou as chairman/CEO and reports his 23.5% stake, with no ultimate controlling shareholder. It reports 921 full-size embodied humanoid sales across mixed families and describes Walker, Cruzr, model and servo development. These are issuer disclosures. UBTECH — 2026-08-28; UBTECH — undated/current record

Analysis

Strategic thesis

Zhou can direct an established humanoid organisation across bodies, components, models and customer applications, giving UBTECH balanced strategic power if its commercial breadth produces reusable capabilities rather than fragmented projects with weak operating economics. Humanoid engineering and customer tasks can reinforce model learning and product iteration. Reuse requires comparable data, reliable components and fewer custom integrations across the different product families.

Analysis

Explicit assumption

Humanoid sales translate into sustained useful operation, cash collection and reusable learning rather than primarily one-off customised projects.

Analysis

Strongest counter-case

The business remains loss-making, and reported humanoid totals span different bodies and purposes. Zhou has substantial executive power but neither a majority stake nor unlimited control over financing and partners. Confidence: A direct humanoid organisation and disclosed commercial business support the thesis; unaudited segment claims, task economics and financing remain important uncertainties.

Analysis

Forward scenarios through 2030

Base: UBTECH expands selected humanoid products and supported customer applications. Upside: Reusable bodies, models and service methods establish a consequential humanoid platform. Downside: Customisation, weak collections and financing demands dilute technological progress.

Analysis

What to monitor

  1. 01Humanoid product mix, cash collection and repeat orders.
  2. 02Useful work, interventions and lifecycle cost by robot family.
  3. 03Cross-family learning and component reuse with limited custom engineering.

Analysis

Research boundaries

Corporate cash and listed-company financing; no market-value substitution. 23.5% stake at June 30; issuer states no ultimate controlling shareholder; board constraints remain. The full capital, talent, compute, data, manufacturing, distribution, architecture, integration, dependence and governance record is structured in the snapshot.

UBTECH Walker S2: reported product sales and development; UBTECH Walker C1: commercial humanoid programme; UBTECH Cruzr Y1: wheeled humanoid programme; UBTECH Thinker 1.0: company reported model release.

Sources were accessed on September 13, 2026. Undated profiles establish only the current reviewed record; future product, capacity or delivery statements remain plans. Exact budgets, data rights and private delegation are not assumed from the title.

Analysis

Sources (2)